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Abstract
Short chain fatty acids (SCFAs) have recently attracted attention as potential mediators of the effects of gut microbiota on
intestinal inflammation. Some of these effects have been suggested to occur through the direct actions of SCFAs on the
GPR43 receptor in neutrophils, though the precise role of this receptor in neutrophil activation is still unclear. We show that
mouse bone marrow derived neutrophils (BMNs) can chemotax effectively through polycarbonate filters towards a source
of acetate, propionate or butyrate. Moreover, we show that BMNs move with good speed and directionality towards a
source of propionate in an EZ-Taxiscan chamber coated with fibrinogen. These effects of SCFAs were mimicked by low
concentrations of the synthetic GPR43 agonist phenylacetamide-1 and were abolished in GPR43
2/2 BMNs. SCFAs and
phenylacetamide-1 also elicited GPR43-dependent activation of PKB, p38 and ERK and these responses were sensitive to
pertussis toxin, indicating a role for Gi proteins. Phenylacetamide-1 also elicited rapid and transient activation of Rac1/2
GTPases and phosphorylation of ribosomal protein S6. Genetic and pharmacological intervention identified important roles
for PI3Kc, Rac2, p38 and ERK, but not mTOR, in GPR43-dependent chemotaxis. These results identify GPR43 as a bona fide
chemotactic receptor for neutrophils in vitro and start to define important elements in its signal transduction pathways.
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Introduction
The short chain fatty acids (SCFAs) acetate, propionate and
butyrate are by-products of anaerobic bacterial fermentation. High
concentrations of these fatty acids are produced by commensal
microflora in the gastrointestinal tract (concentrations ranging from
20–140 mM) and also by pathogenic bacteria at sites of anaerobic
infection e.g. periodontal disease [1,2]. There has been increasing
interest in the idea that the SCFAs may play an important role in the
body’s immune response to the bacteria that generate them and, in
particular, that they may represent an important link between diet,
gut microflora and the body’s inflammatory response. Further, the
recent discovery that the GPR43 receptor, which is activated by
SCFAs and highly expressed in neutrophils [3–5], may be the main
mechanismthroughwhichSCFAsdirectlyregulate immunecellsand
that mice lacking this receptor respond differently in mouse models of
intestinal inflammation has suggested that this system may provide a
novel avenue for anti-inflammatory therapy, particularly in the
treatment of inflammatory bowel disease, ulcerative colitis and
Crohn’s disease [6,7].
There has been little clarity, however, as to the precise nature of
the effects mediated by SCFAs and the identity of the cells upon
which they act. This has prevented an understanding of the effects
of these molecules on the body’s inflammatory response. Further,
in very similar mouse models of Dextran Sulfate Sodium (DSS)-
induced colitis, loss of GPR43 is reported to either ameliorate or
exacerbate granulocyte infiltration and inflammation in the colon
[6,7]. One of the major obstacles to unraveling the function of
SCFAs and the GPR43 receptor in vivo is the sheer complexity of
the cells and signaling mechanisms at play in defining the delicate
balance between immune system tolerance and inflammation in
response to a breach in barrier integrity. There is now a substantial
body of evidence which suggests that neutrophil recruitment to the
intestinal mucosa is a critical player in defining levels of
inflammation in this organ [8] and SCFAs have been shown to
elicit neutrophil migration in Boyden chambers in vitro and in
sterile air-pouch models in vivo [4,9]. However, this effect of
SCFAs is still relatively poorly characterized and has usually
involved preparations of neutrophils which have already been
exposed to inflammatory mediators (e.g. derived via inflammatory
peritoneal exudates) or in assays which are unable to resolve effects
on adhesion, motility or direction-sensing.
We have investigated in detail, the effects of gradients of SCFAs
on the migration of wild type and GPR43
2/2 mouse bone marrow
derived neutrophils (BMNs) in vitro. Our results establish that
activation of the neutrophil GPR43 receptor cansupport neutrophil
motility and direction sensing which allows neutrophils to efficiently
migrate towards a source of SCFAs. Further, we have implicated
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21205PI3Kc, Rac2, ERK and p38 signaling pathways in the mechanism
by which Gi-coupled GPR43 receptors regulate this chemotactic
response.
Materials and Methods
Ethics Statement
All procedures were submitted to and approved by the institutional
animal care committees of the Institute of Biomedical Sciences
(protocol 051/livro 2) and the Babraham Institute (PPL 80/2335).
Materials
All materials used were of the lowest endotoxin level available
and were purchased from Sigma-Aldrich (Dorset, UK). ERK
(PD184352) and p38 (SB203580) inhibitors were kindly provided
by Simon Cook (Babraham Institute, UK). The mTOR inhibitors
rapamycin and torin were purchased from LC laboratories
(Woburn, USA) or kindly provided by William Festuccia (ICB -
USP, Brazil), respectively. The synthetic GPR43 agonist, 2-(4-
chlorophenyl)-3-methyl-N-(thiazol-2-yl) butanamide, also known
as phenylacetamide-1, was synthesized and kindly provided by
Jonathan Clark (Babraham Institute, UK).
Mouse strains
The p110c
2/2 and Rac2
2/2 mouse strains have been previously
described [10,11]; the GPR43
2/2 mouse strain was produced by
Deltagen (CA, USA) [12] and provided by AstraZeneca Transgenic
and Comparative Genomic R&D (Mo ¨lndal, Sweden). Strains were
maintained on C57BL/66129 backgrounds and were compared
with appropriate strain-matched wild-type controls.
Transwell assay
BMNs in a bone marrow cell suspension were assessed for their
ability to migrate through polycarbonate transwell filters as
described previously [13].
EZ-Taxiscan chamber assay
Mature BMNs were purified from mouse bone marrow as
previously described [14]; these preparations were 75–90%
mature neutrophils based on morphology (cytospin) and FACS
scan (forward/side scatter and Gr1 staining). Purified BMN were
resuspended in assay buffer at 5610
5/ml. The EZ-Taxiscan
chamber (Effector Cell Institute, Tokyo, Japan) was assembled as
previously described [15]. Cell migration (at 37uC) was recorded
every 60 s for 30 min using a 106 objective on Pathway 855
system (BD Biosciences). The glass coverslips used in the chamber
were previously coated with 2.5 mg/ml fibrinogen.
Analysis of migration
The x,y coordinates of each cell were measured using
Metamorph (Molecular Devices,S u n n y v a l e ,U K )a n da n a l y s e d
Figure 1. SCFAs and phenylacetamide induce neutrophil migration in a transwell chamber. Chemotaxis of BMN to the indicated
concentration of propionate (A), butyrate (B), acetate (C), phenylacetamide (p-acetamide) (D) and serine (E) was evaluated in a transwell migration
assay. The level of migration to 1 mM fMLP is shown (filled square in A, note scale). Data show the mean 6 S.E.M. (n=3) number of migrating
neutrophils normalized to the control condition (non-treated). *p,0.05 compared with control condition (one-way ANOVA with Dunnet’s post test).
doi:10.1371/journal.pone.0021205.g001
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using the time tracks application [16]. The speed of the cells
and the migratory index of the cells (MI=distance from origin/
total distance traveled) were obtained as previously described
[14]. Data are expressed as the percentage of motile cells, after
normalizing to account for differences in the purity of
neutrophil preparations.
Western blot analyses
PurifiedBMNs(1610
6) were stimulated with the indicated agonists
at 37uC in HBSS. At the appropriate time, cells were diluted into ice-
cold PBS, sedimented by centrifugation and solubilised into ice-cold
lysis buffer, centrifuged (12,000 g for 10 min, 4uC) and the
supernatants mixed with 46 SDS–PAGE sample buffer. Equal
amounts of protein were subjected to SDS-PAGE and transferred to
Figure 2. SCFAs induce neutrophil chemotaxis in the EZ-Taxiscan Chamber. Centre-zeroed tracks of purified BMN in an EZ-Taxiscan
Chamber migrating towards the indicated concentrations of propionate, phenylacetamide (p-acetamide) or fMLP (the source is at the bottom of the
diagram, scale is in mm) (A). The vector of each cell was measured as it crossed a horizon of 50 mm and these vectors are displayed as a horizon plot.
Each 18u segment of the horizon plot indicates the proportion of cells that were moving within each vector. When the population was significantly
moving in one direction (Raleigh test for unimodal clustering, p,0.05) the mean vector (arrow) and 95% confidence limit (shaded area) is shown. The
tracks presented in A were analysed to show the percentage of motile cells (cells crossing a 50 mm horizon) (B), migratory index (of the motile cells)
(C) and speed (of the motile cells) (D) (mean 6 S.E.M.). *p,0.05 compared with control condition (one-way ANOVA with Dunnet’s post test). The data
in A–D are derived from 8–10 movies.
doi:10.1371/journal.pone.0021205.g002
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(T180/Y182), -p42/44 MAPK (T202/Y204), -PKB (S473) and –S6
ribosomal protein (S240/244) (Cell Signalling Technology, Boston,
MA). Anti-b-cop (kind gift from Nicholas Ktistakis, Babraham
Institute, UK) and -b-actin (Cell Signalling Technology, Boston, MA)
were used as a loading control.
Rac activation
Rac1/2 activation was assessed, using a PAK effector domain
‘pull-down’ assay, as described previously [17]. The GST-PAK-
CRIB domain was purified from frozen pellets of BL21 E. coli
cultures using glutathione sepharose
TM resin. Purified BMN
(2610
6) were stimulated with the indicated agonists at 37uCi n
Figure 3. SCFAs increase neutrophil spreading on a fibrinogen matrix. Purified BMN were mixed with PBS or the indicated concentrations of
agonists and immediately applied to fibrinogen coated plates for 15 or 30 min. Adherent cells were visualized by phase contrast microscopy (326,
Zeiss Axiovert) and the number of adherent (A) or spread (B) neutrophils was then quantitated (7 random fields per replicate). Data are mean 6
S.E.M. (n=3). *p,0.05 compared with control condition (one-way ANOVA with Dunnet’s post test).
doi:10.1371/journal.pone.0021205.g003
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lysis buffer (20% sucrose, 10% glycerol, 50 mM Tris [pH 8.0],
0.2 mM Na2S2O5, 2 mM MgCl2, 2 mM DTT, protease inhibitors
[1 mM PMSF, 1 mg/ml aprotinin, leupeptin, antipain, pepstatin
A]). Lysates were centrifuged (13,000 g) for 3 min at 4uCt o
remove insolubles and then cleared lysates were incubated with
20 ml of glutathione sepharose
TM 4B resin, containing approxi-
mately 20–50 mg of GST-PAK-CRIB, for 15 min at 4uC. Resin
was then washed 3 times with lysis buffer and suspended in 1.666
SDS–PAGE sample buffer. An aliquot was taken from the cleared
lysate and analysed for total cellular Rac. Samples were separated
by 12% SDS-PAGE and analysed by Western blotting. Detection
was made using anti-Rac 1 and -Rac-2 (Millipore, Bedfold, MA).
Statistical analysis
Comparisons were performed using paired t-test and one-way
ANOVA and Dunnet’s multiple comparison post test using Graph
Pad Prism 4.0 Software (San Diego, CA, U.S.A.). The significance
was set at p,0.05.
Results and Discussion
SCFAs induce neutrophil migration through
polycarbonate filters
1Initially, we tested the effect of SCFAs and a recently described
synthetic agonist of the GPR43 receptor, phenylacetamide-1 [18], on
the migration of BMNs through polycarbonate transwell filters.
Increasing concentrations of acetate, propionate, butyrate or phenyl-
acetamide-1 in the lower chamber significantly stimulated neutrophil
transmigration with a biphasic concentration curve typical of many
chemoattractants (figure 1). Optimal concentrations for migration were
in the range 0.1–3 mM for acetate, propionate and butyrate and
10 mM for phenylacetamide-1, which is consistent with the previously
reported effects of these agents on GPR43 receptors [7]. In contrast,
serine, a structurally related substance with no activity on the GPR43
receptor was inactive in these assays (figure 1). The maximum fold
increases above basal levels of migration were approximately 2.5 for
acetate and butyrate, 4 for propionate and 6 for phenylacetamide-1,
which are significant but relatively modest compared to an optimum
concentration of the well-established chemotactic peptide fMLP (12
fold). These results extend previous work investigating the effects of
SCFAs on the migration of human circulating [4] and mouse
peritoneal neutrophils [6] in similar assays and suggest that these
compounds may be effective chemoattractants for naı ¨ve neutrophils.
SCFAs induce neutrophil migration in an Ez-Taxiscan
chamber
The chemotatic response of neutrophils to SCFAs was further
examined using the Ez-Taxiscan chamber. This chamber
permits a real time analysis of neutrophil movement in a well-
defined gradient that is created in a narrow (5 mm) gap between
two glass surfaces, one of which in these experiments is coated
with fibrinogen. Using this technique it is possible to analyze
distinct parameters of neutrophil movement such as direction-
ality and speed and allows a more detailed analysis compared to
filter based assays. The results obtained with purified BMNs
indicated that these cells moved towards a source of propionate
and phenylacetamide-1 with good speed and directionality
(figure 2). Similar results were obtained with acetate and
butyrate (data not shown). The concentrations of SCFAs
required to induce significant neutrophil movement in these
assays were an order of magnitude greater than for the
analogous transwell assays, possibly because the different
chamber geometries elicit different gradient profiles for a given
concentration of chemoattractant and the transwell chamber
presents a 3-dimensional surface for migration.
SCFAs and phenylacetamide-1 induced fewer neutrophils to
move in these gradients compared to fMLP (approximately 22%
versus 60%), and neutrophils moved more slowly (approximately
0.08 versus 0.15 mm/sec) (figures 2B and 2C). However, those
neutrophils that did migrate to SCFAs and phenylacetamide-1
did so with a very similar migratory index to those moving in
gradients of fMLP (figure 2D) and, importantly, the population
was able to significantly move in one direction (as measured by
the Raleigh test), suggesting these compounds were acting as true
chemoattractants with a similar capacity to induce directional
movement (figure 2A).
We also examined the effects of SCFAs on the ability of
purified BMNs to adhere and spread on a fibrinogen matrix.
Acetate, propionate and butyrate had little effect on neutrophil
adhesion but all promoted a significant increase in neutrophil
spreading in this assay (figure 3), suggesting this may be a
component of the effects of these compounds in the Ez-
Taxiscan chemotaxis assays.
SCFAs induceneutrophilmigrationviatheGPR43receptor
The involvement of GPR43 in the chemotatic effect of SCFAs on
BMNs was further investigated using neutrophils isolated from the
bone marrow of GPR43
2/2 (KO) and GPR43 wild type (WT) mice
using both the transwell and Ez-Taxiscan assays. The chemotactic
effect of propionate and phenylacetamide-1 on BMNs was
effectively abolished in cells derived from the GPR43KO in both
assay formats (figure 4). In contrast, however, neutrophils isolated
from either the GPR43KO or WT mice moved equivalently in
response to fMLP (figure 4). This data firmly establishes the GPR43
receptor as a selective mediator of the effects of SCFAs on the
directional movement of mouse neutrophils.
These results extend previous observations suggesting the migration
of mouse peritoneal neutrophils in transwell assays towards acetate
[7], propionate or butyrate [6] depends on GPR43. However, the
lack of effect of GPR43 on neutrophil movement in response to fMLP
c o n t r a s t sw i t hp r e v i o u so b s e r v a t i o n st h a tm o v e m e n to fG P R 4 3
2/2
neutrophils towards C5a or fMLP is substantially enhanced but, is
consistent with the lack of effect of GPR43 on movement towards KC
[6,7]. These disparities are likely due to indirect effects stemming from
the state of activation of the various neutrophil preparations used in
these assays. Neutrophils characteristically undergo a process termed
Figure 4. GPR43
2/2 neutrophils do not migrate in response to propionate or phenylacetamide, but display a normal response to
fMLP. Chemotaxis of wild type (WT) and GPR43
2/2 neutrophils was evaluated in a transwell migration assay (A) and EZ-Taxiscan Chamber (B–C).
Chemotaxis of wildtype or GRR43
2/2 neutrophils in a transwell migration assay was measured to propionate (1 mM), phenylacetamide (p-acetamide,
10 mM) or fMLP (1 mM). Data show the mean 6 S.E.M. (n=3) number of migrating neutrophils normalized to the control condition (non-treated).
*p,0.05 compared to wildtype cells (paired t-test) (A). Chemotaxis of wildtype or GRR43
2/2 neutrophils in an EZ-Taxiscan chamber was measured to
propionate (25 mM), phenylacetamide (p-acetamide, 50 mM) or fMLP (3 mM). The mean 6 S.E.M. (n=3) % of neutrophils migrating (past a 50 mm
horizon) *p,0.05 compared with control condition (paired t-test) (B) and centre-zeroed tracks and horizon plots, as described in figure 1, (C) are
shown. The data in B–C are derived from 6–10 movies.
doi:10.1371/journal.pone.0021205.g004
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PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21205Figure 5. Propionate and phenylacetamide activate PKB, ERK1/2, p38 and Rac1/2 through GPR43 and Gi. Purified BMN were
incubated with PBS, propionate (10 mM), phenylacetamide (25 mM) or fMLP (10 mM) for the indicated times. Whole-cell lysates were prepared
and analyzed by immunoblotting using specific Abs to phosphorylated forms of PKB, ERK1/2, p38 (Ai) or the S6 ribosomal protein (Aii). The
cytosolic proteins b-cop or b-actin served as loading controls. Activation of PKB, ERK1/2 and p38 by phenylacetamide (25 mMf o r6 0s e c o n d s ;
PATM) was also quantified by densitometry in neutrophils isolated from GPR43
2/2 mice (Bi) or neutrophils pre-treated with pertussis toxin
(PTX) (2 mg/mL) (Bii) and are displayed as mean 6 S.E.M. (n=4–5) relative to the wildtype, fMLP-treated, sample. The dashed line indicates the
basal level of phosphorylation in wildtype cells (Bi) or untreated (Bii) cells. In order to assess Rac1 and Rac2 activation, purified BMN were
GPR43 Is a Neutrophil Chemotactic Receptor
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pro-inflammatory substances (such as lipopolysaccharide or cytokines),
that lead to increased sensitivity to subsequent activation by some
stimuli [19]. The preparations of neutrophils used for both our
transwell and Ez-Taxiscan chemotaxis assays were substantially
unprimed, as judged by the size of the augmentation elicited by the
cytokine TNFa in accepted assays of the ‘primed state’, namely Mac-
1 up-regulation and fMLP-stimulated release of reactive oxygen
species (figure S1).
Propionate and phenylacetamide activate signaling
pathways involving PKB, ERK1/2, p38, S6 and Rac1/2
Several neutrophil chemoattractants act through Gi-coupled
GPCRs and phosphoinositide 3-kinase (PI3K), MAPK and Rac1/2
signaling pathways have been implicated downstream of these
receptors in the regulatory networks controlling neutrophil migration
[14,20–23]. The GPR43 receptor has also been shown to couple to Gi
in heterologous expression systems [4] and hence we initially
examined the effect of both propionate and phenylacetamide-1 on
incubated with phenylacetamide (25 mM) or PBS for the indicated time and lysates subjected to GST-PAK-CRIB pull down. A representative
blot is shown (Ci) along with quantified data from 4 independent experiments (Cii)( m e a n6 S.E.M). *p,0.005 compared to PBS control
[ p a i r e dt - t e s t ] )f o rR a c 1a n df o rR a c 2 .
doi:10.1371/journal.pone.0021205.g005
Figure 6. Neutrophil chemotaxis in response to propionate, phenylacetamide or fMLP requires PI3Kc, MAPK, Rac2 but not mTor.
Chemotaxis of wildtype BMN pre-incubated with the indicated inhibitor (200 nM wortmaninn, 1 mM PD184352 or 10 mM SB203580) (Ai), or derived
from wildtype (WT) or p110c
2/2 mice (B) was assessed in response to 25 mM propionate, 50 mM phenylacetamide (P-acetamide) or 3 mM fMLP in an
Ez-Taxiscan chamber. Data are expressed as the mean 6 S.E.M. (n=3) % of neutrophils migrating. *p,0.05 compared with control condition (cells
pretreated with DMSO) (one-way ANOVA with Dunnet’s post test) (Ai), *p,0.05 compared to the wildtype (paired t-test) (B). In addition, chemotaxis
of wildtype BMN pre-incubated with the indicated inhibitor (100 nM rapamycin or 100 nM torin) (Aii), or derived from wildtype (WT) or Rac2
2/2
neutrophils (C) towards 1 mM propionate, 10 mM phenylacetamide or 1 mM fMLP was assessed in a transwell chemotaxis assay and is expressed as
the mean 6 S.E.M. of migrating neutrophils normalized to the control condition (non-treated). The data show a representative result of 2 experiments
each performed in triplicate. *p,0.05 compared to the wildtype (paired t-test).
doi:10.1371/journal.pone.0021205.g006
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and the effect of genetic deletion of GPR43 or pertussis toxin (PTX)-
inactivation of Gi on these responses. Both compounds induced a
highly significant and time-dependent increase in phospho-PKB,
ERK1/2 and p38 (figure 5Ai). Deletion of GPR43 reduced
phenylacetamide-1- (figure 5Bi) and propionate-stimulated phosphor-
ylation of PKB, ERK1/2 and p38 to basal levels but had no effect on
the equivalent fMLP-stimulated responses (figure 5Bi and data not
shown). Further, PTX pre-treatment (2 mg/mL during 2 h [24])
reduced both phenylacetamide-1 and fMLP-stimulated responses to a
similar extent (figure 5Bii). These results strongly suggest propionate-
and phenylacetamide-1-induced activation of PKB, ERK1/2 and p38
in BMNs is mediated by Gi-coupled GPR43 receptors.
Propionate and phenylacetamide-1 also stimulated the phos-
phorylation of the 40S ribosomal protein S6 (figure 5Aii), consistent
withthisbeinganindirecttargetofthePI3K/mTORpathway[25].
We also investigated the ability of phenylacetamide-1 to
activate Rac proteins in BMNs. Phenylacetamide-1 stimulated
a rapid and transient increase in GTP-loading of both Rac1 (2
fold above basal) and Rac2 (3 fold above basal) (figure 5C),
which is very characteristic of Gi-coupled GPCRs in this
system [17].
SCFAs- and phenylacetamide-stimulated chemotaxis
requires PI3Kc, Rac2 and MAPK pathways, but not mTOR
We next evaluated the involvement of PI3K, Rac and MAPK
pathways in the chemotactic response of neutrophils to propionate
and phenylacetamide-1. Neutrophils were pre-incubated with
200 nM wortmaninn (inhibitor of PI3Ks), 1 mM PD184352
(inhibitor of ERK) or 10 mM SB203580 (inhibitor of p38) and then
evaluated for their chemotatic responses to propionate, phenylacet-
amide-1 or fMLP. Inhibition of ERK, p38 and PI3K lead to a
significant reduction in the number of cells migrating in response to
propionate (reductions of 79%, 83% and 92%, respectively),
phenylacetamide (reductions of 75%, 74% and 88%, respectively)
and fMLP (reduction of 52%, 64% and 92%, respectively)
(figure 6A), indicating that the activation of these pathways is
important for the chemotactic effect of SCFAs on neutrophils. In
contrast, inhibition of the mTORC1 complex by rapamycin, or
both the mTORC1 and mTORC2 complexes by the mTOR
inhibitor torin, had no significant effect on fMLP, propionate or
phenylacetamide-1 stimulated chemotaxis (figure 6Aii), despite both
having their anticipated effects on the mTORC1 substrate S6 and
the mTORC2 substrate S473-PKB [25] (figure S1).
We also investigated the involvement of PI3Ks in these chemotactic
responses further by assessing the effects of SCFAs on BMNs purified
from PI3Kc
2/2mice. The Class I PI3K isoform PI3Kchas previously
been implicated in neutrophil chemotaxis responses to fMLP using
assays analogous to those performed here using the Ez-Taxiscan
chamber [14]. We found that loss of PI3Kc dramatically reduced the
number of motile neutrophils in response to propionate, phenylacet-
amide-1 and fMLP (figure 6B). We also investigated chemotactic
responses to phenylacetamide-1, propionate and fMLP in BMNs
purified from Rac2
2/2mice. Rac2 has previously been implicated as a
central player in the regulation of neutrophil chemotaxis downstream
of Gi-coupled GPCRs and PI3Kc [17,20]. We found that chemotaxis
responses to propionate or phenylacetamide-1 were abolished in the
absence of Rac2, to an even greater extent to that seen in response to
fMLP (figure 6C).
The role of SCFAs in neutrophil migration
Our observations establish that the GPR43 receptor is a
neutrophil chemoattractant receptor and is required for the
directional movement of mouse neutrophils towards a source of
acetate, propionate or butyrate in vitro. Further, they strongly
suggest that GPR43 mediates these effects through pertussis toxin
sensitive Gi proteins and a signaling network which includes
PI3Kc, Rac2 and MAPKs.
While it is clear that SCFAs can act as chemoattractants it is
unclear if or how they would function in vivo. The concentrations
of SCFAs required to elicit neutrophil migration in vitro are
$0.1 mM, which are very high compared to other established
chemoattractants. They are also extremely high compared to the
concentrations of ligands required to elicit physiological responses
through other GPCRs, perhaps implying that they are not the
endogenous ligands for GPR43. However, these concentrations
of SCFAs are well within the range that may be anticipated to
occur locally at sites of anaerobic bacterial infection or at lesions
of the intestinal barrier [1,26] and thus, in the absence of a more
effective competitor, it must be assumed that SCFAs will indeed
interact with GPR43 at these locations. It is difficult to imagine
scenarios however, where SCFAs would not be present together
with other more potent chemoattractants (e.g. KC, IL-8, LTB4,
C5a, fMLP, MIP-2, etc) and thus it is not clear what precise role
or importance SCFAs may have in neutrophil migration in vivo.
Further, the two studies that have started to address the role of
GPR43 in neutrophil migration to sites of intestinal inflammation
in vivo present conflicting results, suggesting this receptor may
elicit indirect effects on the complex series of interactions which
define neutrophil recruitment, activity and survival in this
location [6,7]. In addition, SCFAs also act on other cell types
(i.e. intestinal epithelial cells, lymphocytes and macrophages)
possibly through a different mechanism (by inhibiting histone
deacetylase activity) and modulate the production of cytokines
and chemokines involved in the recruitment of leukocytes [27–
30]. Thus there are still many outstanding issues with regard to
the function of SCFAs and the GPR43 receptor in regulating
neutrophil function. Nevertheless, our results start to define the
parameters for their effects on neutrophil migration in vitro and
provide further impetus to investigate this potential interaction in
vivo, which is likely to require the development of new tools to
selectively interfere with either the production or presentation of
SCFAs and their selective recognition by the GPR43 receptor on
neutrophils.
Supporting Information
Figure S1 Priming status of BMNs. (A) BMN in murine bone
marrow cell suspensions were selected by immunostaining against Gr-1
and flow cytometry. Gr-1-positive cells were analysed, by immuno-
staining, for expression of MAC-1 in the presence or absence of 20
ng/ml TNFa. Data shown are mean 6 S.D for three experiments
performed in duplicate. *p,0.05, paired Student’s T-test (B). 1610
6
purified BMN were pre-incubated for 1 hr at 37uC in the absence
(mock primed) or presence (TNFa primed) of TNFa (4.55 ng/ml).
Cells were then incubated with luminol/HRP, prior to addition of
fMLP (10 mM) as described in Materials and Methods S1. Total ROS
responses were measured by chemiluminesence, recorded on a 96 well
plate using a Berthold Microlumat Plus luminometer, as described in
Materials and Methods S1. All incubations were performed in at least
duplicate. Shown are accumulated light emission over 3 min (mean 6
S.E.M) from three experiments, expressed as fold of integrated
response in mock primed cells. *p,0.05, paired Student’s T-test.
(TIF)
Figure S2 mTOR activation. (A) Purified BMN were pre-
incubated with 100 nM torin (inhibitor of mTOR 1 and 2) for
GPR43 Is a Neutrophil Chemotactic Receptor
PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e2120530 minutes and then stimulated with PBS, fMLP (10 mM),
propionate (10 mM) or phenylacetamide (25 mM) for 60 seconds.
Whole-cell lysates were prepared and analyzed by immunoblotting
using specific Abs to phosphorylated forms of PKB or the S6
ribosomal protein. (B) Activation of PKB and S6 ribosomal
protein by PBS, fMLP (10 mM), propionate (10 mM) or
phenylacetamide (25 mM) was also analyzed in BMN pre-
incubated with the inhibitor of mTOR 1, rapamycin (100 nM),
for 30 minutes. b-actin served as loading controls.
(TIF)
Materials and Methods S1.
(DOCX)
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